Albert Bourla, Pfizer CEO (John Thys, Pool/AFP via Getty Images)
October 8, 2021 07:13 AM EDT
Coronavirus

Covid-19 roundup: Pfiz­er, BioN­Tech seek au­tho­riza­tion of vac­cine for 5- to 11-year-olds; Fin­land halts roll­out of Mod­er­na vac­cine in younger men — re­port

Nicole DeFeudis

Editor

Pfiz­er and BioN­Tech have of­fi­cial­ly asked the FDA to au­tho­rize their Covid-19 vac­cine for emer­gency use in chil­dren be­tween the ages of 5 and 11 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Out­look's shares crash as wet AMD drug flunks Phase 3 test

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times